Vimta Labs Limited has informed stock exchanges that its Board of Directors, at their meeting held on May 6, 2026, has recommended the re-appointment of Dr. S. P. Vasireddi (DIN: 00242288) as Executive Chairman of the company. The recommendation was made pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, and was based on the recommendations of the Nomination and Remuneration Committee and the approval of the Audit Committee.

Re-appointment Details

The proposed re-appointment is subject to the approval of shareholders at the ensuing Annual General Meeting. The key details of the re-appointment are outlined below:

As Dr. S. P. Vasireddi has attained the age of 77 years, his re-appointment and continuation as Executive Chairman is subject to approval of the members of the company by way of a special resolution at the ensuing Annual General Meeting, as per the provisions of Section 196(3)(a) of the Companies Act, 2013. He is also liable to retire by rotation.

Profile and Experience

Dr. S. P. Vasireddi is the founder of Vimta Labs and has been associated with the company since its inception, playing a pivotal role in its growth and development over the past four decades. His tenure with the company has spanned several key roles:

• Served as Chairman & Managing Director until July 13, 2013
• Served as Executive Chairman up to June 30, 2018
• Served as Non-Executive Chairman from July 1, 2018 to June 30, 2023
• Resumed the position of Executive Chairman following the above tenure

Dr. Vasireddi brings over four decades of industry experience, with expertise in strategic leadership, business development, and corporate governance, contributing to the company's sustained growth and long-term objectives. He has also been instrumental in setting up a centre of excellence — the VIMTA-UNIDO South Cooperation Training Centre.

Advisory and Governing Board Associations

Given his extensive knowledge and experience, Dr. Vasireddi has been nominated as a member on the Advisory/Governing Boards of several apex scientific bodies. His present/past associations include:

• Member of Central Advisory Committee – Food Safety & Standards Authority of India (FSSAI)
• Member of the Governing Board of NABL
• Chairperson – NABL, Risk Management Committee

Additional Disclosures

The following additional disclosures have been made in accordance with regulatory requirements:

The intimation was filed by Sujani Vasireddi, Company Secretary and Compliance Officer of Vimta Labs, in compliance with SEBI Circular SEBI/HO/CFD/CFD-PoD-1/P/CIR/2023/123 dated July 13, 2023 and Master Circular SEBI/HO/CFD/PoD2/CIR/P/0155 dated November 11, 2024.

Vimta Labs Limited has informed the stock exchanges of the availability of the audio recording of its Q4 FY2025-26 Earnings and Investor Call, held on 06 May 2026. The disclosure was submitted to both BSE Limited and the National Stock Exchange of India Limited in compliance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Earnings Call Disclosure Details

The communication, referenced under VLL\SE\013\2026-27 and dated 06 May 2026, confirms that the audio recording of the Q4 FY2025-26 Earnings Call is now accessible on the company's official website. The key details of the disclosure are summarised below:

Access to Recording

The audio recording of the earnings call is available for stakeholders and investors on the company's website for their information and necessary records. The specific link to the recording is: https://vimta.com/wp-content/uploads/10042586.mp3 .

Regulatory Compliance

The filing was signed by Sujani Vasireddi, Company Secretary and Compliance Officer of Vimta Labs Limited, and submitted to both BSE Limited and the National Stock Exchange of India Limited. The disclosure is in line with the company's obligations under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, ensuring transparency and timely access to investor communications.